BlossomHill Therapeutics, Inc. (NasdaqGS: BLSM)
Health Care · Pharmaceuticals · US
$18.46
+0.22% today · +15.4% 1Y
BlossomHill Therapeutics, Inc. (NasdaqGS: BLSM) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $565.68M and employs 63 people.
Over the last twelve months the share price has gained 15.4%, trading between 15.25 and 17.25.
BLSM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $565.68M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -28.59
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $17.25
- 52-week low
- $15.25
- Avg volume (3M)
- —
- Shares outstanding
- 30.64M
- Employees
- 63
- Next earnings
- —
About BlossomHill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded in June 2020 and is headquartered in San Diego, CA.
- ISIN
- US0951301003
- Founded
- 2020
- Listed since
- Aug 7, 2026
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.06T | $1,182.00 | -0.62% |
| Johnson & JohnsonNYSE: JNJ | $650.67B | $266.31 | -1.37% |
| Merck & Co., Inc.NYSE: MRK | $377.72B | $151.02 | -1.36% |
| Roche Holding AGSWX: ROP | $365.10B | CHF364.00 | -1.17% |
| Novartis AGSWX: NOVN | $300.07B | CHF127.18 | -0.90% |
| AstraZeneca PLCLSE: AZN | $257.89B | £121.14 | -0.98% |
| Novo Nordisk A/SCPSE: NOVO B | $210.23B | Dkr304.95 | -0.93% |
| Pfizer Inc.NYSE: PFE | $161.30B | $28.08 | -0.78% |
Figures last refreshed Aug 18, 2026.